A study of MCLA-158 in the treatment of colorectal cancer

Trial Profile

A study of MCLA-158 in the treatment of colorectal cancer

Planning
Phase of Trial: Phase I/II

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs MCLA 158 (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 28 Apr 2017 According to a Merus media release, company expects to file a CTA for this trial by the end of 2017.
    • 03 Jun 2016 New trial record
    • 01 Jun 2016 According to a Merus media release, the company plans to file an Investigational New Drug Application (IND) with the FDA by the end of year 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top